Endpoints News
Adapting to AI Read in browser
Endpoints News
Tuesday, 7 October 2025
Thank you for reading, dupa dupackia!
basic
UPGRADE
Health Tech Day 2025
Health tech is attracting capital and defying the downturn: from wearable tech to RWE, momentum is building. Join our online session in the AM and in the PM we’re live in person that evening with a reception at NYC’s Book Club Bar. Don’t miss out — seats are limited, get your spot
Where AI is heading
Last week, I caught up with Omada CEO Sean Duffy, fresh off a panel at the Rock Health Summit, where he and Hinge Health CEO Daniel Perez talked about their experiences taking their companies public.
Duffy and I talked about how Omada had launched an AI-powered food mapping tool. With it, users of Omada’s virtual program, which manages conditions like diabetes and hypertension, take photos of their meals. The tool then figures out the nutrient density of the meal, with the goal that users have 50% of their meals classified as nutrient-dense, Duffy told me. 
Duffy said he remembers talking with his co-founder Adrian James about doing something like it in San Francisco’s Dolores Park when the company first got started nearly 15 years ago. “We’re actually able to do it now with AI, because you just couldn’t have otherwise,” he said. The company also has an AI assistant that can help with things like creating recipes. 
“It's been a big innovation push, because we saw where the models were going,” Duffy said of the technology. 
Lately, I’ve been intrigued with how older, existing health tech companies are incorporating AI into their strategies, especially as we’re seeing newer companies start to compete with them. 
Duffy agrees there’s a lot of potential for AI to shake up the industry. "We could be up for, over the next couple of decades, the biggest change in the Fortune 500 that's ever happened," Duffy told me.
But, he said, it’ll depend on who incorporates AI successfully. If Omada didn’t act first, a newer company could try and displace Omada. It's betting that its relationships with existing customers will give it an edge over newer entrants. 
“It's kind of an adapt or not moment,” Duffy added. 
- Lydia
Here’s what’s new
Mid-stage health tech startups struggling to raise, report finds
Health tech fundrais­ing has been split in­to two ex­tremes of megarounds and mid-stage bot­tle­necks so far this year.
Live at 2 p.m. ET: Vijay Pande on what's next after a16z, his outlook of AI in bio
Over a decade af­ter start­ing a16z's biotech and health­care in­vest­ing prac­tice, Vi­jay Pande left the sto­ried Sil­i­con Val­ley ven­ture-cap­i­tal firm this sum­mer.

Pande joins Post-Hoc Live today at 2:00 p.m. ET to share his outlook on the always-changing AI bio world and the promises and pitfalls of investing in it in 2025. Join us on our YouTube livestream or set a calendar reminder to watch the conversation live.
Replacing surgery
A chart shows percent change in GLP-1 use compared to bariatric surgery use.

Procedures including bariatric surgeries may be "imperiled" by new drugs like GLP-1s, healthcare analytics company Trilliant Health found. Based on claims data, Trilliant saw a 745% increase in GLP-1 use from 2018 to 2023. Over that same time period, bariatric surgery volume didn’t change. 

This week in health Тech

Hims’ chief operating officer Nader Kabbani stepped down after less than half a year in the role. Hims' chief commercial officer Mike Chi will replace Kabbani, as the Amazon veteran begins an advisory role at Hims instead this fall.

Virtual therapy company Talkspace acquired Wisdo Health, an online mental health platform that connects users with peer support coaches and communities.

Hazel Health laid off around 11% of its staff, Behavioral Health Business reported. The San Francisco-based company, which works with schools to provide virtual health and therapy appointments for students, told BHB in a statement that the cuts are a way to sustain its growth over the last few years, as well as bring on AI and automation tools.

Costco is the latest retailer offering a cash price for Ozempic and Wegovy, selling a four-week supply for $499 out of pocket. GoodRx, CVS and Walmart started offering the same discount earlier this year.
John Carroll
Editor & Founder
Arsalan Arif
Publisher & Founder
Igor Yavych
Architect & Founder
Valentin Manov
Creative Director
Ryan McRae
Chief Revenue Officer
Amanda Florez
Chief of Staff
Drew Armstrong
Executive Editor
Liam Chua
Chief Technical Officer
Jaimy Lee
Deputy Editor
Lydia R. Pflanzer
Deputy Editor
Zachary Brennan
Senior Editor
Max Gelman
Senior Editor
Julie O'Meara
Executive Director, Brand Partnerships
Melissa Nazzaro
Executive Director, Brand Partnerships